"There's no question that Amazon is a competitor in the marketplace," CVS Health CEO Larry Merlo tells analysts.
Opioid companies will likely face more federal lawsuits this year, Vox reports.
PharMerica, a U.S. pharmacy manager for long-term care facilities, said it agreed to be acquired by a newly formed company controlled by buyout firm KKR for $1.4 billion.
California's cigarette tax hike is proving to be hazardous to Big Tobacco and retailers alike.
Second-quarter earnings season kicks off, and the bulk of the growth will come from a select few sectors.
As Amazon celebrates its third Prime Day, the stocks of some of the retailers it's been crushing are hitting rock bottom.
Credit Suisse gave an update on its favorite stocks mid-way through the year.
Retail consultant Jan Kniffen speculates that Sears could file for bankruptcy as early as next month.
The Walgreens-Rite Aid deal puts it in a strong position if companies like Amazon decide to enter the pharmacy business, Walgreens CEO says.
The "Halftime Report" traders take investors through some of the day's biggest movers.
Walgreens CEO thinks the company remains in a strong position to compete, even if entrants such as Amazon move into the market.
Some of the names on the move ahead of the open.
Walgreens canceled its merger deal with Rite Aid on Thursday and replaced it with a new agreement.
The "Squawk on the Street" crew discusses Walgreen's failed deal with Rite Aid and the company's quarterly results.
John Ransom, Raymond James analyst, talks about Walgreens' "tactical retreat" from its deal with Rite Aid.
Walgreens Boots Alliance canceled its previous merger deal with Rite Aid and replaced it with a new agreement, which also impacts Fred's.
The "Squawk Box" crew reports the new deal involves Walgreens buying nearly 2,200 Rite Aid stores for nearly $5.2 billion in cash.
Rite Aid stock is up over 11 percent in midday trading Monday, and the FTC looks increasingly to approve Rite Aid's merger with Walgreens.
Shares of Rite Aid are up over 11 percent on Monday as doubts ease over approval of Walgreens deal.
Drugstore chain Walgreens had, at one point, hosted about 40 Theranos blood-testing centers.